A phase 1, safety, tolerability, and pharmacokinetics study of bisnorcymserine, a highly selective inhibitor of butyrylcholinesterase. [PDF]
Tzieras I +7 more
europepmc +1 more source
Verification of Exposure to Cholinesterase Inhibitors: Generic Detection of OPCW Schedule 1 Nerve Agent Adducts to Human Butyrylcholinesterase [PDF]
Marcel J. van der Schans +4 more
openalex +1 more source
Red Macroalgae as Sources of Antioxidant and Multifunctional Ingredients for Functional Foods: A Biorefinery Approach. [PDF]
Nunes N +3 more
europepmc +1 more source
Deciphering the mechanisms underlying the dual-target inhibition of carbohydrate-digesting and neurodegenerative enzymes by Syzygium aromaticum (L.) Merr. & L.M. via molecular docking and dynamics simulations. [PDF]
Ojo OA +8 more
europepmc +1 more source
Development of an in-vivo active reversible butyrylcholinesterase inhibitor [PDF]
Urban Košak +24 more
openalex +1 more source
The interplay between homocysteine, oxidative stress, and butyrylcholinesterase activity in the pathogenesis of schizophrenia. [PDF]
Naifar M +5 more
europepmc +1 more source

